Open Label,Phase II Trial of MAB Dose Escalation OF Bicalutamide For Biochemical Failure In Prostate Cancer Patients. (CHICS)
This study has been completed.
Sponsor:
Canadian Urology Research Consortium
Collaborator:
AstraZeneca
Information provided by:
Canadian Urology Research Consortium
ClinicalTrials.gov Identifier:
NCT00554086
First received: November 5, 2007
Last updated: May 13, 2011
Last verified: May 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | September 2010 |
| Primary Completion Date: | September 2009 (Final data collection date for primary outcome measure) |